Hyperbaric Oxygen Therapy involves breathing pure oxygen inside a pressurized chamber, typically set at 1.5 to 3 times normal atmospheric pressure. Under these conditions, oxygen dissolves more readily into blood plasma, reaching tissues that standard breathing cannot adequately supply. This noninvasive treatment originally gained recognition for decompression sickness in divers but has since expanded to address crush injuries, carbon monoxide poisoning, and radiation-induced wounds. Patients recline in monoplace or multiplace chambers during sessions lasting 60 to 90 minutes, experiencing nothing more than mild ear pressure during pressurization.
The Core Mechanism of Hyperbaric Oxygen Therapy
At the heart of this medical innovation lies HBOT as a catalyst for superoxygenation. When pressurization increases ambient pressure, oxygen binds not only to hemoglobin but also saturates plasma ten to fifteen times above normal levels. This surplus oxygen stimulates angiogenesis—the growth of new blood vessels—and enhances neutrophil function to fight infection. Leukocyte activity improves significantly, while swelling decreases around injured areas. For chronic wounds like diabetic foot ulcers, this process reverses local hypoxia, a state where low oxygen halts healing. The therapy also inhibits toxin production from certain bacteria, making it valuable for gas gangrene and tetanus management.
Clinical Applications and Emerging Frontiers
Practitioners apply this protocol across medicine, from treating osteoradionecrosis following cancer therapy to salvaging failing skin grafts. Recent research explores its potential in traumatic brain injury and sudden hearing loss, though evidence remains mixed. Insurance typically covers FDA-approved uses like non-healing wounds, but experimental applications require out-of-pocket payment. Patients undergo screening to exclude those with untreated pneumothorax or certain respiratory conditions. As mobile hyperbaric units become available, accessibility improves, though proper supervision remains critical. With ongoing trials investigating stroke recovery and post-COVID neurological symptoms, this therapy continues to redefine how physicians leverage basic physical laws for targeted healing.